# HYDROCODONE BITARTRATE AND IBUPROFEN
> **ANDA204575** · Abbreviated New Drug Application (Generic) · Sponsor: AUROLIFE PHARMA LLC · Approved 2016-06-02
## Drug
- **FDA Application Number:** ANDA204575
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** HYDROCODONE BITARTRATE AND IBUPROFEN
- **Generic name:** HYDROCODONE BITARTRATE AND IBUPROFEN
- **Active ingredients:** HYDROCODONE BITARTRATE; IBUPROFEN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AUROLIFE PHARMA LLC
- **Manufacturer:** Aurolife Pharma, LLC
- **First approval:** 2016-06-02
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204575)
---
*MORVS · CC0 1.0*